Stockreport

New Palvella Director Brings Rare Disease Insight To Low Valued Stock [Yahoo! Finance]

Palvella Therapeutics, Inc.  (PVLA) 
PDF Palvella Therapeutics (NasdaqCM:PVLA) has appointed Dr. John D. Doux to its Board of Directors. Dr. Doux is a board-certified dermatologist and experienced healthcare [Read more]